DUBLIN, Fabrairu 24, 2022-(WIRE KASUWANCI) - "Kasuwancin Kiwon Lafiyar Sinawa, Girman, Hasashen 2022-2027, Juyin Masana'antu, Ci gaban, Raba, Tasirin COVID-19, Binciken Kamfani" an ƙara shi zuwa ResearchAndMarkets. com tayi.
Kasuwar In-vitro Diagnostics (IVD) ta kasar Sin ita ce cibiyar samar da kiwon lafiya a duniya, kuma an kiyasta ta kai dalar Amurka biliyan 18.9 a shekarar 2027. Ban da haka, kasar Sin ita ce babbar kasuwar dakin gwaje-gwajen asibiti a Asiya, kuma tana daya daga cikin kasashen da suka fi saurin girma a duniya. wuraren kiwon lafiya.
Abin sha'awa shi ne, a cikin 'yan shekarun da suka gabata, yawan bunkasuwar tattalin arzikin kasar Sin yana da kyau, wanda ya haifar da karuwar GDP a kowace shekara.Bugu da ƙari, yanayin yanayin IVD na kasar Sin a tarihi ya kasance ana sarrafa shi ta hanyar manyan masu samar da kayayyaki na duniya, tare da ƙananan kayan aikin gida da masu samar da kima.Bugu da ari, neman canji, kamfanin farawa yana ganin juyin halitta na dandamali na bincike da kuma ƙididdigar da ke nuna saurin ganowa ga nau'o'in alamomin jini.
Masana'antar In-Vitro Diagnostics ta China tana haɓaka tare da CAGR mai lamba biyu na 16.9% yayin 2021-2027
Masana'antar IVDs ta kasar Sin tana girma tsawon shekaru kuma tana da muhimmin tushe na bincike da samarwa na duniya.A kasar Sin, akwai ingantaccen bukatu na asibiti don ci gaban ci gaban kamfanoni na IVD.Koyaya, sabbin buƙatun bincike suna ci gaba da fitowa, suna buƙatar dakunan gwaje-gwaje na asibiti don aiwatar da ƙarin ayyukan gwaji da kamfanoni na IVD don ƙirƙira sabbin fasahohi da samfuran.Bugu da kari, tare da kyautata zaman rayuwar jama'ar kasar Sin, da saurin tsufa na jama'ar kasar Sin, bukatun kula da lafiyar iyali na karuwa;Don haka wannan hanyar za ta zama muhimmin mahimmin ci gaban masana'antun in vitro diagnostics.
Ta yaya Coronavirus ya amfana da Ci gaban Ci gaban Kasuwar In-Vitro Diagnostics China
COVID-19 ya kara haɓaka haɓakar masana'antar bincikar In-vitro a China.Kamar yadda kasar Sin ta kiyaye manufar COVID ba ta dace ba, don haka don cimma wannan adadi mai yawa na gwajin PCR da gwaje-gwajen Antigen na gaggawa yana bukatar a yi.Saboda bambance-bambancen COVID kamar Alpha, Beta, Gamma Delta, Delta Plus, da kwanan nan Omnicorn, gwajin PCR da gwaje-gwajen Antigen na gaggawa za su ci gaba da faruwa da yawa.A cewar mawallafin, Girman Kasuwancin In-Vitro Diagnostics na China ya kasance dala biliyan 7.4 a cikin 2021.
Sashin Binciken Kwayoyin Halitta Yana Rijista Ƙarfin Girma
A cikin rahoton, an kasafta kasuwa cikin sunadarai na asibiti, Immunoassay, Binciken Kwayoyin Halitta, Microbiology, Haematology, da Kula da Glucose na Jini (SMBG), Gwajin Kulawa (POCT), da Coagulation.A cikin IVD, ɗayan ci gaba mafi mahimmanci ya kasance ta hanyar kayan aikin gano kwayoyin halitta.Kamar yadda bincike ya nuna, maganin sarkar polymerase shine mafi yawan al'ada na gaba na binciken kwayoyin.
Bayan haka, samfuran PCR na lokaci guda suna gano ƙwayoyin cuta, ƙwayoyin cuta, fungi, da ƙwayoyin cuta, suna ba da damar dakunan gwaje-gwajen ƙwayoyin cuta don rage farashi da fitar da kyakkyawan sakamako a cikin binciken kwayoyin.Abin sha'awa, ana amfani da gwaje-gwajen gano ƙwayoyin ƙwayoyin cuta don gano takamaiman jeri a cikin DNA ko RNA (ciki har da polymorphism nucleotide guda ɗaya (SNP), gogewa, sake tsarawa, shigarwa, da sauransu) waɗanda ƙila ko ƙila ba za a haɗa su da kowace cuta ba.
Manyan ƴan wasa a Kasuwar IVD ta China
Manyan kamfanonin IVD na kasa da kasa sun riga sun sami babban matsayi a cikin kasuwar kasar Sin kuma suna wakiltar yuwuwar shingen gasa ga masu shigowa kasuwa.Manyan 'yan wasan sun hada da Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories, Danaher Corporation, da bioMerieux SA.
Kamfanonin suna jin daɗin albarkatu mafi girma na kuɗi don biyan farashi mai alaƙa da takaddun samfur, gwaji na asibiti, da wakilcin wakilai.Bugu da ƙari, waɗannan kamfanoni na iya yin abubuwan da suka dace don kafa rarraba kai tsaye da ayyukan masana'antu na gida.
Yankunan Rufe
Kasuwar Chemistry na Clinical
Immunoassay Market
Kasuwar Binciken Kwayoyin Halitta
Kasuwar Microbiology
Kasuwar Hematology
Kula da Kai na Kasuwar Glucose (SMBG).
Kasuwar Gwajin Kulawa (POCT).
Kasuwar Coagulation
Lokacin aikawa: Maris 11-2022